These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24703645)

  • 1. [Alopecia areata in a patient treated with antitubercular drugs].
    Tella E; Daubercies G; Sin C; Marchal A; Sigal ML; Mahé E
    Ann Dermatol Venereol; 2014 Apr; 141(4):295-7. PubMed ID: 24703645
    [No Abstract]   [Full Text] [Related]  

  • 2. Consider rifampin BUT be cautious.
    Ashkin D; Julien J; Lauzardo M; Hollender E
    Chest; 2006 Dec; 130(6):1638-40. PubMed ID: 17166975
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of tuberculosis in the adult].
    Schrappe M; Wassermann K; Kroegel C
    Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinico-laboratory diagnosis of adverse reactions in children to antitubercular drugs in different combinations].
    Kazakov KS; Zakharova RI; Absadykova FT
    Probl Tuberk; 1990; (9):40-2. PubMed ID: 2274509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four-month, four-drug preventive therapy for inactive pulmonary tuberculosis.
    Goldberg SV; Duchin JS; Shields T; Nolan CM
    Am J Respir Crit Care Med; 1999 Aug; 160(2):508-12. PubMed ID: 10430721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unilateral and painless development of isoniazid induced gynecomastia during re-treatment of pulmonary tuberculosis.
    Kumar L; Gupta R; Puri MM; Jaiswal A; Srinath ; Murar A; Behera D
    J Assoc Physicians India; 2011 Nov; 59():733-5. PubMed ID: 22616343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse reaction to antimycobacterials administered as a combination tablet with no reaction to the same drugs in isolation.
    Kingston M; Childs K; Carlin E
    Sex Transm Infect; 2001 Oct; 77(5):392-3. PubMed ID: 11588298
    [No Abstract]   [Full Text] [Related]  

  • 8. Antituberculous therapy and acute liver function.
    Bourke SJ; White J; Stenton SC; Hendrick DJ
    Lancet; 1995 May; 345(8958):1171-2. PubMed ID: 7786347
    [No Abstract]   [Full Text] [Related]  

  • 9. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 10. [Directly observed treatment for tuberculosis in a Buenos Aires City hospital].
    González C; Sáenz C; Herrmann E; Jajati M; Kaplan P; Monzón D
    Medicina (B Aires); 2012; 72(5):371-9. PubMed ID: 23089112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Question 1: what are the options for treating latent TB infection in children?
    Gwee A; Coghlan B; Curtis N
    Arch Dis Child; 2013 Jun; 98(6):468-74. PubMed ID: 23661667
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical relevance of reduced bioavailability of rifampicin.
    Joshi SR
    J Assoc Physicians India; 1999 Sep; 47(9):943-4. PubMed ID: 10778683
    [No Abstract]   [Full Text] [Related]  

  • 13. 3-month daily rifampicin and isoniazid compared to 6- or 9-month isoniazid for treating latent tuberculosis infection in children and adolescents less than 15 years of age: an updated systematic review.
    Assefa Y; Assefa Y; Woldeyohannes S; Hamada Y; Getahun H
    Eur Respir J; 2018 Jul; 52(1):. PubMed ID: 29748305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gynaecomastia during antituberculosis chemotherapy with isoniazid.
    Dixit R; Sharma S; Nawal CL
    J Assoc Physicians India; 2008 May; 56():390-1. PubMed ID: 18700651
    [No Abstract]   [Full Text] [Related]  

  • 15. Twelve months of isoniazid compared with four months of isoniazid and rifampin for persons with radiographic evidence of previous tuberculosis: an outcome and cost-effectiveness analysis.
    Jasmer RM; Snyder DC; Chin DP; Hopewell PC; Cuthbert SS; Antonio Paz E; Daley CL
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1648-52. PubMed ID: 11069790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.
    Jawahar MS; Rajaram K; Sivasubramanian S; Paramasivan CN; Chandrasekar K; Kamaludeen MN; Thirithuvathas AJ; Ananthalakshmi V; Prabhakar R
    Trop Med Int Health; 2005 Nov; 10(11):1090-8. PubMed ID: 16262733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid oral desensitization to isoniazid, rifampin, and ethambutol.
    Kim JH; Kim HB; Kim BS; Hong SJ
    Allergy; 2003 Jun; 58(6):540-1. PubMed ID: 12757467
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-tuberculosis chemotherapy and management of adverse reactions].
    Kuwabara K
    Nihon Rinsho; 2011 Aug; 69(8):1389-93. PubMed ID: 21838035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Compliance, tolerance and effectiveness of a short chemoprophylaxis regimen for the treatment of tuberculosis].
    Martínez Alfaro E; Solera J; Serna E; Cuenca D; Castillejos ML; Espinosa A; Sáez L
    Med Clin (Barc); 1998 Oct; 111(11):401-4. PubMed ID: 9834911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of tuberculosis. Drug combinations, therapeutic problems and results in a 10-year case load].
    Morland L
    Tidsskr Nor Laegeforen; 1990 Nov; 110(28):3608-11. PubMed ID: 2260057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.